Ionis Pharmaceuticals, Inc. Long-term Debt and Lease Obligation
Ionis Pharmaceuticals, Inc. (IONS) had Long-term Debt and Lease Obligation of $539.11 million as of 2020-12-31, per its 10-K filed 2021-02-24.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:LongTermDebtAndCapitalLeaseObligations · last filed 2021-02-24
- 2020-12-31: Long-term Debt and Lease Obligation $539.11M.
- 2019-12-31: Long-term Debt and Lease Obligation $785.50M.
- 2011-12-31: Long-term Debt and Lease Obligation $145.57M.
- 2011-09-30: Long-term Debt and Lease Obligation $4.72M.
| Period end | Long-term Debt and Lease Obligation | Long-term Debt and Lease Obligation as first filed |
|---|---|---|
| 2020-12-31 | $539.11M 10-K · filed 2021-02-24 | |
| 2019-12-31 | $785.50M 10-K · filed 2021-02-24 | |
| 2011-12-31 | $145.57M 10-K · filed 2012-02-29 | |
| 2011-09-30 | $4.72M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $5.46M 10-Q · filed 2011-08-08 | |
| 2011-03-31 | $4.94M 10-Q · filed 2011-05-06 | |
| 2010-12-31 | $148.76M 10-K · filed 2012-02-29 | $5.72M 10-K · filed 2011-03-01 |
| 2010-09-30 | $4.30M 10-Q · filed 2010-11-05 | |
| 2010-06-30 | $5.62M 10-Q · filed 2010-08-09 | |
| 2009-12-31 | $11.48M 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |